The weekly litigation news digest is live. Subscribe now

IP Verse

Sarepta Therapeutics competitive analysis

Latest oppositions filed by Sarepta Therapeutics

Explore patent oppositions filed by Sarepta Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 1, 2026
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by Sarepta Therapeutics

EP3018211
Antisense Nucleic AcidsNATIONAL CENTER OF NEUROLOGY AND PSYCHIATRYMay 6, 2020

Latest PTAB cases involving Sarepta Therapeutics

Discover the latest PTAB cases involving Sarepta Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Jan 2, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Sarepta Therapeutics

IPR2026-00166Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEPending
IPR2026-00167Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEPending
IPR2026-00168Dec 2, 2025SAREPTA THERAPEUTICSGENZYMEPending
IPR2026-00149Nov 25, 2025SAREPTA THERAPEUTICSGENZYMEPending
IPR2026-00150Nov 25, 2025SAREPTA THERAPEUTICSGENZYMEPending
IPR2025-01194Jun 26, 2025SAREPTA THERAPEUTICSGENZYMEDiscretionary Denial
IPR2025-01195Jun 26, 2025SAREPTA THERAPEUTICSGENZYMEDiscretionary Denial
IPR2024-00580Feb 21, 2024SAREPTA THERAPEUTICSTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAFinal Written Decision - Appealed
IPR2021-01134Jun 21, 2021SAREPTA THERAPEUTICSNATIONAL CENTER OF NEUROLOGY AND PSYCHIATRYTerminated
IPR2021-01135Jun 21, 2021SAREPTA THERAPEUTICSNATIONAL CENTER OF NEUROLOGY AND PSYCHIATRYTerminated

Peer Comparison New

IP litigation analysis comparing Sarepta Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 1, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SAREPTA THERAPEUTICS1 - 15 -
GENZYME - 19210
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY - 2 - 7
NIPPON SHINYAKU - 6 - -